
LOWVELO Fellow
Timmy Samec, a cancer researcher and patient, is the first LOWVELO graduate fellow at Hollings Cancer Center.
On April 2, MUSC Hollings Cancer Center will host its first LOWVELO Trainee Symposium focused on building a successful career in cancer research.
The event, which will be held virtually, will highlight the world of research and scientific discovery, with a day dedicated to career development for trainees in all levels of the research pipeline — from STEM-focused high school students to senior scientists.
Renowned keynote speakers Anita Hopper, Ph.D., professor of Molecular Genetics at The Ohio State University, and John Carpten, Ph.D., professor and chair of Translational Genomics and director of the Institute of Translational Genomics at Keck School of Medicine of the University of Southern California, will discuss their research, provide perspective on their career success and highlight the importance of diversity in translational cancer research.
The symposium will also feature research presentations and Q&A sessions from senior scientists and postdoctoral, graduate and undergraduate students along with a panel discussion led by leaders within Hollings’ research programs.
Hollings’ associate director for Education and Training Chanita Hughes-Halbert, Ph.D., who also holds the AT&T Distinguished Endowed Chair for Cancer Equity, said, “As the only NCI-designated cancer center in South Carolina, Hollings has a unique obligation to promote the education and professional development of the next generation of cancer researchers. The first annual LOWVELO Symposium will highlight the new discoveries and advances in cancer research that are being made by the students, trainees and junior faculty at Hollings and will provide an opportunity for emerging scholars and scientists to interact with leaders in the field.”
“We are grateful to the individuals and corporate sponsors who have contributed to our education and training programs and are excited for this opportunity to share our discoveries with the community,” added Hughes-Halbert, who also co-leads Hollings’ Cancer Control Research Program.
The symposium will take place from 8 a.m. to 3:45 p.m. and is open to all MUSC faculty and trainees. Those who wish to attend may register here.
This symposium supports the mission of Hollings in nurturing the next generation of cancer researchers, which also is an important goal of LOWVELO, an annual grassroots event that raises money for innovative and lifesaving cancer research at Hollings. The third annual LOWVELO will take place on Nov. 6, and registration will open March 24.
Timmy Samec, a cancer researcher and patient, is the first LOWVELO graduate fellow at Hollings Cancer Center.
Hollings Cancer Center awarded funding to five scientists as part of its fellowship program to train the next generation of cancer researchers.
LOWVELO is an annual fundraising event that raises money for lifesaving cancer research at MUSC Hollings Cancer Center.